Purchase Order HHSN272201000168P
Award Date 12/9/09
Potential Completion Date 1/8/10
Potential Value $6.2K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Other
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Bio Basic Canada Inc. The contract is for the purchase of 672 units of gene synthesis services at $0.39 per unit, for a total ceiling value of $3,232.91. The contract was awarded on December 4, 2009, with a completion date of January 15, 2010. This award does not have a set-aside designation and is a purchase order with an...
- The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $20,000 firm fixed price purchase order to Genscript USA Inc. to provide custom gene synthesis services. The contract will support NIH's research efforts at its Bethesda, Maryland campus through December 31, 2023. Genscript will deliver custom gene synthesis products to NIH researchers as part of the Institute's work to advance understanding of diseases...
- <p>This is a $23,549.66 purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services, to Bio Basic Canada Inc. The contract is for the purchase of synthetic DNA related to respiratory syncytial virus (RSV) research. The contract has a completion date of September 16, 2010 and was awarded on August 17, 2010. This contract is not associated with a set-aside program.</p>
- This federal contract award, with ID HHSN272201200181P, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the Department of Health and Human Services (HHS). The $3,528.90 Firm Fixed Price contract was awarded to Bio Basic Canada Inc. on January 25, 2012 for the delivery of 1,200 units of synthetic genes related to the nucleoprotein of the Human Metapneumovirus (HMPV) at a unit price of $0.30, for a total of $360.00. The contract has an ultimate completion...
- This federal contract award to Genscript USA Inc. is for $182,897.61 to provide custom gene synthesis services to the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH) within the Department of Health and Human Services. The contract is a firm fixed-price purchase order with no set-aside designation, and the services include DNA synthesis, subcloning, and plasmid preparation to support HIV research being conducted at the NIH...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Genscript USA Inc., a biotechnology company, for gene synthesis services. The $17,000.35 contract has a completion date of December 30, 2020 and was awarded on December 31, 2019. The services provided under this contract supported biomedical research and public health initiatives carried out by the agency. Genscript has...
- This firm fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $3,943.72 contract is for custom gene synthesis services to support NIAID's biomedical research programs. Genscript, a for-profit organization, has a strong track record of providing specialized molecular biology products and services to...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Bio-Synthesis, Inc. (doing business as Dnaexam) for the custom synthesis of oligonucleotides. The contract has a ceiling value of $29,580.00 and an ultimate completion date of February 28, 2010. The agency indicates a high demand and usage level for these oligonucleotides, particularly for a recombinant vaccine project against...
- The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) awarded a $37,889.60 firm fixed-price purchase order contract to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey, for custom gene synthesis and expression services. This requirement was sole-sourced to Genscript due to their specialized expertise in producing the specific gene constructs needed to support NIAID's vaccine research and development efforts. The contract...
- This $7,768.05 firm fixed-price purchase order was awarded to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables, by the National Institute of Allergy and Infectious Diseases (NIAID) for gene synthesis services. The contract has no set-aside designation and was awarded on May 28, 2013 with a completion date of May 30, 2013. Life Technologies serves as a prime contractor across multiple federal agencies, including the NIH, DoD, USDA, DOC, and DOJ,...